Holen Sie sich die Stockscreener-App
0.4622
0.02%
-0.0122
Schlusskurs vom Vortag:
$0.45
Offen:
$0.458
24-Stunden-Volumen:
1.68M
Relative Volume:
4.53
Marktkapitalisierung:
$11.35M
Einnahmen:
$56.04M
Nettoeinkommen (Verlust:
$-20.39M
KGV:
-0.1894
EPS:
-2.44
Netto-Cashflow:
$-6.84M
1W Leistung:
+8.15%
1M Leistung:
+28.40%
6M Leistung:
-33.54%
1J Leistung:
-33.84%
1-Tages-Spanne:
$0.44
$0.5488
1-Wochen-Bereich:
$0.355
$0.5488
52-Wochen-Spanne:
$0.2801
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Vergleichen Sie COSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.4589 | 11.35M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
709.00 | 85.53B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
291.89 | 55.74B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
151.95 | 32.30B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
66.79 | 8.03B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.3893 | 546.39M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Geode Capital Management LLC Increases Stock Position in Cosmos Health Inc. (NASDAQ:COSM) - Defense World
Stocks of Cosmos Health Inc (COSM) are poised to climb above their peers - Sete News
Financial Metrics Unveiled: Cosmos Health Inc (COSM)’s Key Ratios in the Spotlight - DWinneX
Behind Cosmos Health Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
Cosmos Health Inc [COSM] Shares Fall Approximately -34.71% Over the Year - knoxdaily.com
Evaluating COSM’s financial ratios for a profitable investment - uspostnews.com
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued a - GuruFocus
Cosmos Health CEO boosts stake with $526,000 share purchase - Investing.com
Cosmos Health CEO boosts stake with $526,000 share purchase By Investing.com - Investing.com UK
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares - GlobeNewswire
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 - The Globe and Mail
Should You Buy PayPal Stock on the Dip in May 2025? - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
COSM Stock Sees Surge of Approximately 15.01% in Last Five Days - knoxdaily.com
Cosmos Health CEO acquires $63,000 in stock at $0.36 per share By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $63,000 in stock at $0.36 per share - Investing.com Nigeria
Cosmos Health Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Cosmos Health Inc (COSM) deserves closer scrutiny - uspostnews.com
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed By Investing.com - Investing.com Nigeria
Cosmos Health CEO acquires shares worth $208,000 By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires shares worth $208,000 - Investing.com Australia
Cosmos Health Reports Full-Year 2024 Results: Revenue - GlobeNewswire
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million | COSM Stock News - GuruFocus
Cosmos Health Inc. Reports Year-End 2024 Financial Results Highlighting Revenue Growth and Strategic Developments - Nasdaq
Cosmos Health Inc. SEC 10-K Report - TradingView
Cosmos Health Further Expands Facility Upgrades Program at Cana - GuruFocus
Cosmos Health secures deal for antiseptic drug production By Investing.com - Investing.com South Africa
Cosmos Health secures deal for antiseptic drug production - Investing.com
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L - GlobeNewswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract… - Informazione.it
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Cosmos Health expands into Albania with new supplement brand - Investing.com
Cosmos Health expands into Albania with new supplement brand By Investing.com - Investing.com South Africa
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order - The Manila Times
Cosmos Health Launches Sky Premium Life in Albania through - GlobeNewswire
Cosmos Health Lands Major $300K Deal in Strategic Albanian Market Entry - Stock Titan
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cosmos Health Inc-Aktie (COSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Apr 24 '25 |
Buy |
0.40 |
177,234 |
71,000 |
5,327,448 |
| Siokas Grigorios | Chief Executive Officer |
Apr 23 '25 |
Buy |
0.40 |
205,000 |
82,000 |
5,150,214 |
| Siokas Grigorios | Chief Executive Officer |
Apr 22 '25 |
Buy |
0.36 |
175,000 |
63,000 |
4,945,214 |
| Siokas Grigorios | Chief Executive Officer |
Apr 21 '25 |
Buy |
0.32 |
654,912 |
208,000 |
4,770,214 |
| Siokas Grigorios | Chief Executive Officer |
Mar 04 '25 |
Buy |
0.53 |
85,714 |
45,000 |
4,115,302 |
| Siokas Grigorios | Chief Executive Officer |
Mar 03 '25 |
Buy |
0.49 |
132,572 |
65,000 |
4,029,588 |
| Siokas Grigorios | Chief Executive Officer |
Feb 24 '25 |
Buy |
0.56 |
354,296 |
200,000 |
3,897,016 |
| Siokas Grigorios | Chief Executive Officer |
Jan 30 '25 |
Buy |
0.66 |
51,414 |
34,000 |
4,255,103 |
| Siokas Grigorios | Chief Executive Officer |
Jan 22 '25 |
Buy |
0.77 |
38,900 |
30,000 |
4,203,689 |
| Siokas Grigorios | Chief Executive Officer |
Jan 17 '25 |
Buy |
0.86 |
29,158 |
25,000 |
4,164,789 |
0.00%
6.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):